Inogen logo
Inogen INGN
$ 5.71 -1.38%

Quarterly report 2025-Q3
added 11-06-2025

report update icon

Inogen Income Statement 2011-2026 | INGN

Annual Income Statement Inogen

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

195 M 161 M 365 M 669 M 1.08 B 988 M 3.19 B 2.61 B 1.28 B 645 M 495 M - - -

Shares

23.7 M 23.2 M 22.9 M 22.5 M 22 M 21.8 M 21.3 M 20.7 M 20.1 M 19.4 M 16.2 M - - -

Historical Prices

8.23 6.95 16 29.7 48.9 44.3 151 122 64.4 33.2 30.6 - - -

Net Income

-35.9 M -102 M -83.8 M -6.33 M -5.83 M 21 M 51.8 M 21 M 20.5 M 11.6 M 6.83 M 25.4 M 564 K -2 M

Revenue

336 M 316 M 377 M 358 M 308 M 362 M 358 M 249 M 203 M 159 M 113 M 75.4 M 48.6 M 30.6 M

Cost of Revenue

181 M 189 M 224 M 182 M 170 M 190 M 180 M 128 M 106 M 82.7 M 57 M 36.5 M 24.6 M -

Gross Profit

155 M 127 M 154 M 176 M 138 M 172 M 179 M 121 M 97.3 M 76.3 M 55.5 M 39 M 23.9 M 14.7 M

Operating Income

-42.5 M -109 M -85.2 M 9.24 M -12 M 19.8 M 37.9 M 27.6 M 22.9 M 15.1 M 10.5 M 4.46 M 829 K -

Interest Expense

850 K 468 K -862 K -710 K 5.84 M -229 K -696 K 1.3 M 6 K 22 K 449 K 562 K 493 K -

EBITDA

-21.5 M -91.2 M -61.7 M 30.9 M 6.56 M 33.6 M 49.2 M 39.9 M 36.4 M 29.1 M 22.6 M 13 M 5.81 M 1.48 M

Operating Expenses

197 M 236 M 239 M 167 M 150 M 152 M 141 M 93.6 M 74.4 M 61.2 M 45 M 34.5 M 23.1 M 16.4 M

General and Administrative Expenses

72.6 M 75.3 M 43.9 M 37.9 M 38.6 M 37.1 M 38 M 37.6 M 31.8 M 25.7 M 17.9 M 13.8 M 8.29 M 5.62 M

All numbers in USD currency

Quarterly Income Statement Inogen

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

27.1 M 27 M 25.2 M 23.9 M 23.8 M 23.6 M 23.4 M 23.3 M 23.2 M 23.1 M 23 M 22.9 M 22.9 M 22.8 M 22.8 M 22.7 M 22.6 M 22.4 M 22.2 M 22 M 22 M 22 M 21.9 M 21.9 M 21.8 M 21.8 M 21.8 M 21.5 M 21.3 M 21.2 M 21 M 20.9 M 20.8 M 20.6 M 20.5 M 20.3 M 20.2 M 20 M 19.8 M 19.7 M 19.4 M 19.3 M 19.2 M 19.1 M 18.3 M 18.2 M 9.44 M 281 K 277 K 274 K 272 K - - - - - - - -

Net Income

-5.29 M -4.15 M -6.17 M - -5.96 M -5.59 M -14.6 M - -45.7 M -9.83 M -20.3 M - -9.51 M -3.44 M -14.2 M - 12.2 M 5.1 M -732 K -5.12 M -1.7 M 2.58 M -1.59 M -1.38 M 6.86 M 10.2 M 5.3 M 10 M 16.4 M 14.6 M 10.8 M -606 K 7.34 M 8.34 M 5.93 M 5.26 M 5.25 M 7.49 M 2.52 M 3.86 M 2.7 M 3.46 M 1.57 M 1.52 M 2.13 M 2.29 M 6.8 M 22 M 774 K 1.96 M 24.7 M - - - - - - - -

Revenue

92.4 M 92.3 M 82.3 M - 88.8 M 88.8 M 78 M - 84 M 83.6 M 72.2 M - 105 M 103 M 80.4 M - 93.1 M 102 M 86.9 M 74 M 74.3 M 71.7 M 88.5 M 78.9 M 91.8 M 101 M 90.2 M 86.5 M 95.3 M 97.2 M 73.6 M 63.8 M 63.1 M 58 M 46 M 50.9 M 47.2 M 45.6 M 32.8 M 40.4 M 29.2 M 32.4 M 23 M 29.1 M 19.4 M 20.5 M 14.9 M 19.8 M 12.1 M 12.8 M 8.9 M - - - - - - - -

Cost of Revenue

51.1 M 50.9 M 45.9 M - 47.5 M 46 M 43.7 M - 50.2 M 49.6 M 41.4 M - 62.6 M 57.1 M 45.4 M - 45.4 M 51.2 M 47.1 M - 41.3 M 38.9 M 50.1 M - 48.4 M 50.8 M 45.8 M - 46.5 M 48.8 M 41.3 M - 35.9 M 32.6 M 26.8 M - 29.3 M 28.4 M 21.7 M - 21.4 M 23.2 M 17.7 M - 14.7 M 15.3 M 11.7 M - 10.1 M 9.1 M 7.63 M - - - - - - - -

Gross Profit

41.3 M 41.3 M 36.4 M - 41.3 M 42.7 M 34.4 M - 33.8 M 34 M 30.7 M - 42.8 M 46.3 M 35 M - 47.7 M 50.3 M 39.9 M 34.1 M 33 M 32.7 M 38.4 M 33.9 M 43.3 M 50.2 M 44.4 M 43.6 M 48.8 M 48.5 M 37.7 M 30.8 M 33.2 M 31.6 M 25.7 M 24.7 M 25.1 M 26.2 M 21.3 M 20 M 19.4 M 20.8 M 16 M 13.8 M 14.6 M 15.1 M 11.9 M 10.2 M 9.64 M 11.1 M 8.12 M - - - - - - - -

Operating Income

-7.12 M -6.13 M -7.66 M - -7.79 M -7.06 M -16.3 M - -46.7 M -11.8 M -21.9 M - -10.3 M -2.88 M -13.6 M - 6.37 M 11.7 M -2.13 M - -1.97 M -2.35 M -2.18 M - 8.11 M 12.1 M 4.86 M - 10.4 M 14 M 8.7 M - 8.33 M 8.5 M 5.57 M - 5.4 M 8.02 M 3.28 M - 3.71 M 5.34 M 2.52 M - 3.57 M 3.96 M 1.55 M - 886 K 2.39 M 633 K - - - - - - - -

Interest Expense

606 K 701 K 356 K - 687 K 134 K 143 K - -398 K 337 K 237 K - -12 K -722 K -433 K - -466 K 304 K -310 K - -54 K 5.7 M -60 K - -503 K 145 K -120 K - 8 K -1.05 M 444 K - 264 K 523 K 207 K - 1 K 2 K 3 K - 5 K 6 K 7 K - 104 K 203 K 133 K - 113 K 95 K 104 K - - - - - - - -

EBITDA

-3.18 M -2.12 M -2.47 M - -3.58 M -2.91 M -11 M - -42.3 M -7.51 M -17.8 M - -6.51 M 822 K -7.83 M - 22.2 M 14.7 M 2.97 M - 11.7 M 6.59 M 2.28 M - 17.3 M 17.7 M 7.65 M - 18.9 M 19.8 M 11.7 M - 17.6 M 14.8 M 8.78 M - 15.7 M 14.9 M 6.72 M - 14.2 M 12.3 M 5.96 M - 12.3 M 9.55 M 4.21 M - 6.88 M 6.04 M 2.29 M - - - - - - - -

Operating Expenses

48.4 M 47.5 M 44 M - 49.1 M 49.8 M 50.6 M - 80.5 M 45.8 M 52.6 M - 53.1 M 49.1 M 48.6 M - 41.3 M 38.7 M 42 M - 35 M 35.1 M 40.5 M - 35.2 M 38.1 M 39.6 M - 38.4 M 34.4 M 29 M - 24.8 M 23.1 M 20.2 M - 19.7 M 18.2 M 18 M - 15.7 M 15.5 M 13.5 M - 11.1 M 11.2 M 10.4 M - 8.76 M 8.66 M 7.48 M - - - - - - - -

General and Administrative Expenses

18.2 M 16.9 M 16.2 M - 19.3 M 18.6 M 17.1 M - 17 M 14.6 M 18.9 M - 14.8 M 12.7 M 15.2 M - 9.26 M 5.22 M 12.5 M - 8.59 M 9.72 M 9.78 M - 8.52 M 8.84 M 9.68 M - 9.98 M 9.68 M 9.57 M - 10.4 M 9.86 M 8.34 M - 8.7 M 7.24 M 7.87 M - 6.41 M 6.94 M 5.72 M - 4.7 M 3.91 M 4.05 M - 3.53 M 3.43 M 2.83 M - - - - - - - -

All numbers in USD currency

The income statement is one of the three key financial reports of a company Inogen (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
AxoGen AxoGen
AXGN
$ 33.22 1.87 % $ 1.47 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 7.01 2.04 % $ 503 M israelIsrael
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 3.76 -1.7 % $ 130 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 13.29 1.41 % $ 1.9 B usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
$ 255.19 -12.51 % $ 7.2 B usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 36.35 -3.09 % $ 5.42 K usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 41.59 -0.28 % $ 1.28 B usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 74.77 0.88 % $ 110 B usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 112.22 0.66 % $ 195 B usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 4.8 0.63 % $ 179 M franceFrance
Delcath Systems Delcath Systems
DCTH
$ 9.25 1.43 % $ 264 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 13.44 3.07 % $ 363 M usaUSA
Electromed Electromed
ELMD
$ 24.2 3.82 % $ 205 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
InMode Ltd. InMode Ltd.
INMD
$ 14.36 0.38 % $ 1.14 B israelIsrael
IRadimed Corporation IRadimed Corporation
IRMD
$ 99.81 -0.03 % $ 1.26 B usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 85.46 0.23 % $ 2.87 B usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
Penumbra Penumbra
PEN
$ 339.82 0.32 % $ 13.1 B usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
FONAR Corporation FONAR Corporation
FONR
$ 18.55 0.05 % $ 122 M usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 1.47 3.17 % $ 57.5 M usaUSA
Globus Medical Globus Medical
GMED
$ 87.89 0.76 % $ 11.9 B usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 11.29 4.46 % $ 869 M usaUSA
Myomo Myomo
MYO
$ 0.82 0.41 % $ 5.78 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
$ 75.22 2.28 % $ 2.12 B costa-ricaCosta-rica